Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Kemin Biologics Partners with ilender to Launch MEFLUVACtm H5 PLUS 8 Vaccine to Empower the Peruvian Poultry Industry Against Avian Influenza


DES MOINES, Iowa, Oct. 25, 2023 /PRNewswire/ -- Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, will launch the MEFLUVACtm H5 PLUS 8 vaccine in partnership with ilender in Latin America to assist in building immunity against the highly pathogenic Avian Influenza.

Kemin Biologics, the global veterinary vaccine division of Kemin, will debut the new vaccine in Peru at the event and roadshow starting on October 30 in the Peruvian cities of Lima, Trujillo and Chincha. At this event, policy and distribution stakeholders, along with customers from the poultry meat and layer industries, will gather to discuss vaccinology and risk management programs. The industry leaders will focus on the importance of addressing major pathogens that compromise animal performance and food security for the growing population.

"We are excited to introduce our technology and best practices to empower the poultry industry in Peru and Latin America to mitigate the growing threat of highly pathogenic Avian Influenza," said Dr. Ricardo Neto, Technical Service Manager, Kemin Biologics. "The high degree of homology with local strains makes MEFLUVACtm H5 PLUS 8 the vaccine of choice."

With a focus on delivering integrated, custom solution platforms that build immunity and protect animal performance, Kemin Biologics works closely with customers worldwide to address important needs and is committed to putting animal welfare at the forefront to help prevent hunger and disease associated with malnutrition while supporting the global food supply.

"The launch of MEFLUVACtm H5 PLUS 8 is a major milestone for Kemin Biologics' expansion into the Latin America market," said Dr. Matias Jansen, Regional Business Director, Kemin Biologics. "Together with our partner, ilender, we will be able to reach producers all across Peru and support them with vaccination strategies that are based on our expertise and experiences from all over the world."

To learn more about MEFLUVACtm H5 PLUS 8, visit our website.

About Kemin Industries

Kemin Industries (www.kemin.com) is a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services. The company supplies over 500 specialty ingredients for human and animal health and nutrition, pet food, aquaculture, nutraceutical, food technologies, crop technologies, textile, biofuel and animal vaccine industries.

For over half a century, Kemin has been dedicated to using applied science to address industry challenges and offer product solutions to customers in more than 120 countries. Kemin provides ingredients to feed a growing population with its commitment to the quality, safety and efficacy of food, feed and health-related products.

Established in 1961, Kemin is a privately held, family-owned-and-operated company with more than 3,000 global employees and operations in 90 countries, including manufacturing facilities in Belgium, Brazil, China, Egypt, India, Italy, San Marino, Singapore, South Africa and the United States. 

About ilender

ilender (www.ilendercorp.com) is a Peruvian company, part of a Armejo Yepez Group, with more than 30 years in the poultry industry, that works with a team of professionals with high trajectory to provide the best value proposition through reliable solutions and programs, developing strategic alliances together with our customers in the search for innovation and continuous improvement.

Quality and confidence are the differentiator, ilender has one of the most modern veterinary pharmaceutical plants in the world, and the company is committed to ensuring bio safety with the purpose of nurturing families with the best quality protein.

ilender was founded in 1989, operating successfully in the markets of Peru, Bolivia, Brazil, Chile, Colombia, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Panama, Paraguay and Venezuela.

Media Contacts: 
Kemin Industries ? Lauren M.G. Burt, Head of Worldwide Communications, [email protected]
ilender ? Maria Luisa Melendez, Services Marketing Coordinator, [email protected]

© Kemin Industries, Inc. and its group of companies 2023. All rights reserved. ® TM Trademarks of Kemin Industries, Inc., U.S.A.
Certain statements, product labeling and claims may differ by geography or as required by government requirements.

 

SOURCE Kemin Industries


These press releases may also interest you

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 10:12
AnX Robotica, the leader in advanced gastrointestinal visualization technologies, is happy to announce the appointment of two industry veterans to the leadership team....

at 07:13
Webblogic®, a pioneer in medical device manufacturing technology, is set to launch its comprehensive range of advanced manufacturing and packaging equipment specifically designed for the Medical Device, Pharma, and Life Sciences industries. In...



News published on and distributed by: